The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta

Journal of Clinical Investigation

Volumn 110, Issue 9, 2002, Pages 1293-1299

  Rauch, Frank ^a   Travers, Rose ^a   Plotkin, Horacio ^a   Glorieux, Francis H ^a  

^a SHRINERS HOSPITAL FOR CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PAMIDRONIC ACID;

ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; BONE BIOPSY; BONE DYSPLASIA; BONE MASS; BONE METABOLISM; BONE MINERALIZATION; BONE REMODELING; CANCELLOUS BONE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICAL BONE; DRUG EFFECT; HUMAN; HUMAN TISSUE; ILIAC BONE; MALE; MORPHOMETRICS; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOGENESIS IMPERFECTA; OSTEOLYSIS; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS;

EID: 0036841117     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0215952     Document Type: Article

References (31)

1. Sillence, D.O., Senn, A., and Danks, D.M. 1979. Genetic heterogeneity in osteogenesis imperfecta. J. Med. Genet. 16:101-116.
2. Rowe, D.W., and Shapiro, J.R. 1998. Osteogenesis imperfecta. In Metabolic Bone Disease and Clinically Related Disorders. L.V. Avioli and S.M. Krane, editors. Academic Press Inc. San Diego, California, USA. 651-695.
3. Rauch, F., Travers, R., Parfitt, A.M., and Glorieux, F.H. 2000. Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone. 26:581-589.
4. Glorieux, F.H., et al. 1998. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N. Engl. J. Med. 339:947-952.
5. Plotkin, H., et al. 2000. Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age. J. Clin. Endocrinol. Metab. 85:1846-1850.
6. Astrom, A., and Soderhall, S. 2002. Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta. Arch. Dis. Child. 86:356-364.
7. Glorieux, F.H., et al. 2000. Normative data for iliac bone histomorphometry in growing children. Bone. 26:103-109.
8. Glorieux, F.H., et al. 2000. Type V osteogenesis imperfecta: A new form of brittle bone disease. J. Bone Miner. Res. 15:1650-1658.
9. Glorieux, F.H., et al. 2002. Osteogenesis imperfecta type VI: A form of brittle bone disease with a mineralization defect. J. Bone Miner. Res. 17:30-38.
10. Ward, L.M., et al. 2002. Osteogenesis imperfecta type VII: An autosomal recessive form of brittle bone disease. Bone. 31:12-18.
11. Parfitt, A.M., et al. 1987. Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2:595-610.
12. Carter, D.R., Bouxsein, M.L., and Marcus, R. 1992. New approaches for interpreting projected bone densitometry data. J. Bone Miner. Res. 7:137-145.
13. Hamill, P.V., et al. 1979. Physical growth: National Center for Health Statistics percentiles. Am. J. Clin. Nutr. 32:607-629.
14. Bollen, A.M., and Eyre, D.R. 1994. Bone resorption rates in children monitored by the urinary assay of collagen type 1 cross-linked peptides. Bone. 15:31-34.
15. Korkko, J., et al. 1998. Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type I: Identification of common sequences of nullallele mutations. Am. J. Hum Genet. 62:98-110.
16. Ganguly, A., Rock, M.J., and Prockop, D.J. 1993. Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: Evidence for solvent-induced bends in DNA heteroduplexes. Proc. Natl. Acad. Sci. USA. 90:10325-10329.
17. Bravenboer, N., et al. 1999. Bone histomorphometric evaluation of pamidronate treatment in clinically manifest osteoporosis. Osteoporos. Int. 9:489-493.
18. Chavassieux, P.M., et al. 1997. Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J. Clin. Invest. 100:1475-1480.
19. Chavassieux, P.M., et al. 2000. Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: A histomorphometric analysis of transiliac biopsies. J. Bone Miner. Res. 15:754-762.
20. Burr, D.B., et al. 1997. Bone microdamage and skeletal fragility in osteoporotic and stress fractures. J. Bone Miner. Res. 12:6-15.
21. Burr, D.B. 2002. Targeted and nontargeted remodeling. Bone. 30:2-4
22. Fleisch, H. 1998. Bisphosphonates: Mechanisms of action. Endocr. Rev. 19:80-100.
23. Cbapurlat, R.D., Delmas, P.D., Liens, D., and Meunier, P.J. 1997. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J. Bone Miner. Res. 12:1746-1752.
24. Orwoll, E., et al. 2000. Alendronate for the treatment of osteoporosis in men. N. Engl. J. Med. 343:604-610.
25. Reid, I.R., et al. 2002. Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N. Engl. J. Med. 346:653-661.
26. Boivin, G.Y., Chavassieux, P.M., Santora, A.C., Yates, J., and Meunier, PJ. 2000. Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone. 27:687-694.
27. Parfitt, A.M., Travers, R., Rauch, F., and Glorieux, F.H. 2000. Structural and cellular changes during bone growth in healthy children. Bone. 27:487-494.
28. Halasy-Nagy, J.M., Rodan, G.A., and Reszka, A.A. 2001. Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis. Bone. 29:553-559.
29. Fazzalari, N.L., Moore, AJ., Byers, S., and Byard, RAV. 1997. Quantitative analysis of trabecular morphogenesis in the human costochondral junction during the postnatal period in normal subjects. Anat. Rec. 248:1-12.
30. Pataki, A., et al. 1997. Effects of short-term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: A comparative histomorphomerric study on the cancellous bone formed before, during, and after treatment. Anat. Rec. 249:458-468.
31. Frost, H.M. 1990. Skeletal structural adaptations to mechanical usage (SATMU). I. Redefining Wolff's law: The bone modeling problem. Anat. Rec. 226:403-413.